Arthrosi Therapeutics Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
34
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.55B
Arthrosi Therapeutics General Information
Description
Developer of biotechnology drugs designed to reduce flare and tophi in gout patients. The company provides clinical-stage research and development services focused on therapy for gout and chronic kidney disease, enabling medical professionals to provide strong uric acid reduction and the resolution of joint damage caused by tophi.
Contact Information
Website
www.arthrosi.com(Operating Subsidiary)
Corporate Office
- 9855 Towne Centre Drive
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 9855 Towne Centre Drive
- Suite 200
- San Diego, CA 92121
- United States
Arthrosi Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 09-Feb-2026 | $1.55B | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series E) | 23-Jun-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 12-Jul-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C3) | 02-Mar-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C2) | 15-Nov-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 22-Oct-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 30-Jan-2019 | $11M | $15.3M | Completed | Generating Revenue | |
| 1. Seed Round | 29-Jun-2018 | $4.28M | $4.28M | Completed | Generating Revenue |
Arthrosi Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C-3 | ||||||||
| Series C-2 | ||||||||
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 2,444,445 | $0.000100 | 8% | $4.5 | $4.5 | 1x | $4.5 | 4% |
| Series A | 2,646,995 | $0.000100 | 8% | $1.85 | $1.85 | 1x | $1.85 | 4.33% |
Arthrosi Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arthrosi Therapeutics Patents
Arthrosi Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4457221-A1 | Preparation of a compound for the treatment of gout or hyperuricemia | Pending | 30-Dec-2021 | ||
| EP-4457221-A4 | Preparation of a compound for the treatment of gout or hyperuricemia | Pending | 30-Dec-2021 | ||
| US-20250100988-A1 | Preparation of a compound for the treatment of gout or hyperuricemia | Pending | 30-Dec-2021 | ||
| WO-2023125667-A1 | Preparation of a compound for the treatment of gout or hyperuricemia | Inactive | 30-Dec-2021 | ||
| US-20250066316-A1 | Crystalline forms of a compound for treating or preventing gout or hyperuricemia | Pending | 02-Dec-2021 | C07D307/80 |
Arthrosi Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arthrosi Therapeutics Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CR Biotech | Venture Capital | Minority | ||
| Changrong Capital | Venture Capital | Minority | ||
| FengHe Fund Management | Venture Capital | Minority | ||
| Guangrun Health Industry | Other | Minority | ||
| H7 BioCapital | Venture Capital | Minority |
Arthrosi Therapeutics Investments (1)
Arthrosi Therapeutics’s most recent deal was a Joint Venture with Ruianbo Pharmaceutical. The deal was made on 17-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ruianbo Pharmaceutical | 17-Aug-2021 | Joint Venture | Drug Discovery |
Arthrosi Therapeutics FAQs
-
When was Arthrosi Therapeutics founded?
Arthrosi Therapeutics was founded in 2018.
-
Where is Arthrosi Therapeutics headquartered?
Arthrosi Therapeutics is headquartered in San Diego, CA.
-
What is the size of Arthrosi Therapeutics?
Arthrosi Therapeutics has 34 total employees.
-
What industry is Arthrosi Therapeutics in?
Arthrosi Therapeutics’s primary industry is Drug Discovery.
-
Is Arthrosi Therapeutics a private or public company?
Arthrosi Therapeutics is a Private company.
-
What is the current valuation of Arthrosi Therapeutics?
The current valuation of Arthrosi Therapeutics is .
-
What is Arthrosi Therapeutics’s current revenue?
The current revenue for Arthrosi Therapeutics is .
-
How much funding has Arthrosi Therapeutics raised over time?
Arthrosi Therapeutics has raised $299M.
-
Who are Arthrosi Therapeutics’s investors?
CR Biotech, Changrong Capital, FengHe Fund Management, Guangrun Health Industry, and H7 BioCapital are 5 of 19 investors who have invested in Arthrosi Therapeutics.
-
When was Arthrosi Therapeutics acquired?
Arthrosi Therapeutics was acquired on 09-Feb-2026.
-
Who acquired Arthrosi Therapeutics?
Arthrosi Therapeutics was acquired by Swedish Orphan Biovitrum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
